DBV Technologies (DBVT) Other Accumulated Expenses (2019 - 2026)

DBV Technologies (DBVT) reported Other Accumulated Expenses of $10.8 million for Q1 2026, up 98.27% year-over-year from $5.4 million in Q1 2025, and down 31.65% quarter-over-quarter from $15.8 million in Q4 2025.

DBV Technologies (DBVT) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 8 years of Other Accumulated Expenses data on file, last reported at $10.8 million in Q1 2026.

  • Other Accumulated Expenses for Q1 2026 came in at $10.8 million, up 98.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.8 million (up 98.27% YoY), and the FY2025 annual result was $15.8 million, up 89.72% from the prior year.
  • Other Accumulated Expenses eased to $10.8 million in Q1 2026 per DBVT's latest filing, from $15.8 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $15.8 million in Q4 2025 and troughed at $5.0 million in Q1 2024.
  • A 5-year average of $8.4 million and a median of $8.4 million in 2025 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2026: Other Accumulated Expenses sank 34.9% in 2022, then soared 98.27% in 2026.
  • A 5-year view of Other Accumulated Expenses shows it stood at $9.2 million in 2022, then decreased by 3.0% to $8.9 million in 2023, then decreased by 6.78% to $8.3 million in 2024, then jumped by 89.72% to $15.8 million in 2025, then sank by 31.65% to $10.8 million in 2026.
  • Business Quant data shows DBVT's Other Accumulated Expenses at $10.8 million in Q1 2026, $15.8 million in Q4 2025, and $8.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.80 Mn
Dec 31, 2025 15.80 Mn
Sep 30, 2025 8.45 Mn
Jun 30, 2025 7.52 Mn
Mar 31, 2025 5.45 Mn
Dec 31, 2024 8.33 Mn
Sep 30, 2024 7.79 Mn
Jun 30, 2024 6.16 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 8.93 Mn
Sep 30, 2023 8.67 Mn
Jun 30, 2023 7.26 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 9.21 Mn
Sep 30, 2022 8.62 Mn
Jun 30, 2022 8.78 Mn
Mar 31, 2022 8.72 Mn
Dec 31, 2021 12.36 Mn
Sep 30, 2021 12.66 Mn
Jun 30, 2021 12.67 Mn